Lipoteichoic acids selectively stimulate rat mast cells to cysteinyl leukotriene generation and affect mast cell migration after tumor necrosis factor (TNF)-priming

Immunology Letters

Volumn 109, Issue 2, 2007, Pages 138-144

  Brzezińska Błaszczyk, Ewa ^a   Rdzany, Rafał S ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cysteinyl leukotrienes; Lipoteichoic acid; Mast cell; Mast cell migration

Indexed keywords

BACTERIAL ANTIGEN; HISTAMINE; INTERLEUKIN 6; LAMININ; LIPOTEICHOIC ACID; PEPTIDOLEUKOTRIENE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; BACILLUS SUBTILIS; BACTERIAL CELL WALL; BACTERIAL INFECTION; CELL ACTIVATION; CELL MIGRATION; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GRAM POSITIVE BACTERIUM; HISTAMINE RELEASE; HOST RESISTANCE; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS AUREUS; TREATMENT RESPONSE;

ANIMALS; ANTIBODIES; BACILLUS SUBTILIS; CELL MOVEMENT; CYSTEINE; FEMALE; HISTAMINE RELEASE; LEUKOTRIENES; LIPOPOLYSACCHARIDES; MAST CELLS; RATS; RATS, WISTAR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947393162     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.02.001     Document Type: Article

References (55)

1. Williams C.M.M., and Galli S.J. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 105 (2000) 847-859
2. Krishnaswamy G., Kelley J., Johnson D., Youngberg G., Stone W., Huang S.K., et al. The human mast cell: functions in physiology and disease. Front Biosci 6 (2001) D1109-D1127
3. Crivellato E., Beltrami C.A., Mallardi F., and Ribatti D. The mast cell: an active participant or an innocent bystander?. Histol Histopathol 19 (2004) 259-270
4. Maurer M., Theoharides T., Granstein R.D., Bischoff S.C., Bienenstock J., Henz B., et al. What is the physiological function of mast cells?. Exp Dermatol 12 (2003) 886-910
5. Marshall J.S., and Jawdat D.M. Mast cells in innate immunity. J Allergy Clin Immunol 114 (2004) 21-27
6. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol Rev 77 (1997) 1033-1079
7. Arock M., Ross E., Lai-Kuen R., Averlant G., Gao Z., and Abraham S.N. Phagocytic and tumor necrosis factor alpha response of human mast cells following exposure to gram-negative and gram-positive bacteria. Infect Immun 66 (1998) 6030-6034
8. Malaviya R., Ross E.A., MacGregor J.I., Ikeda T., Little J.R., Jakschik B.A., et al. Mast cell phagocytosis and FimH-expressing enterobacteria. J Immunol 152 (1994) 1907-1914
9. Shin J.S., Gao Z., and Abraham S.N. Involvement of cellular caveolae in bacterial entry into mast cells. Science 289 (2000) 785-788
10. Malaviya R., Twesten N.J., Ross E.A., Abraham S.N., and Pfeifer J.D. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 156 (1996) 1490-1496
11. Frandji P., Oskéritzian C., Cacaraci F., Lapeyre J., Peronet R., David B., et al. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol 151 (1993) 6318-6328
12. Di Nardo A., Vitiello A., and Gallo RL. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 170 (2003) 2274-2278
13. Varadaradjalou S., Feger F., Thieblemont N., Hamouda N.B., Pleau J.-M., Dy M., et al. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 33 (2003) 899-906
14. Komisar J., Rivera J., Vega A., and Tseng J. Effects of staphylococcal enterotoxin B on rodent mast cells. Infect Immun 60 (1992) 2969-2975
15. Montemurro P., Nishioka H., Dundon W.G., de Bernard M., Del Giudice G., Rappuoli R., et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells. Eur J Immunol 32 (2002) 671-676
16. Watanabe Y., Todome Y., Ohkuni H., Sakurada S., Ishikawa T., Yutsudo T., et al. Cysteine protease activity and histamine release from the human mast cell line HMC-1 stimuled by recombinant streptococcal pyrogenic exotoxin B/streptococcal cysteine protease. Infect Immun 70 (2002) 3944-3947
17. Malaviya R., Gao Z., Thankavel K., van der Merwe P.A., and Abraham SN. The mast cell tumor necrosis factor α response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci USA 96 (1999) 8110-8115
18. Patella V., Casolaro V., Bjorck L., Marone G., and Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells. J Immunol 145 (1990) 3054-3061
19. Malaviya R., and Abraham S.N. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leukoc Biol 67 (2000) 841-846
20. McCurdy J.D., Olynych T.J., Maher L.H., and Marshall J.S. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 170 (2003) 1625-1629
21. Supajatura V., Ushio H., Nakao A., Akira S., Okumura K., Ra C., et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 109 (2002) 1351-1359
22. el-Lati S.G., Dahinden C.A., and Church M.K. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 102 (1994) 803-806
23. Wojtecka-Łukasik E., and Maśliński S. Fibronectin and fibrinogen degradation products stimulate PMN-leukocyte and mast cell degranulation. J Physiol Pharmacol 43 (1992) 173-181
24. Kopp E., and Medzhitov R. Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol 15 (2003) 396-401
25. McCurdy J.D., Lin T.-J., and Marshall J.S. Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 70 (2001) 977-984
26. Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis 2 (2002) 171-179
27. Han S.H., Kim J.H., Martin M., Michalek S.M., and Nahm M.H. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Infect Immun 71 (2003) 5541-5548
28. Shore P.A., Burkhalter A., and Cohn V.H. A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 127 (1959) 182-186
29. Brzezińska-Błaszczyk E., and Wasiela M. Vaginal bacterial flora activates rat peritoneal mast cells. Int J Immunopathol Pharmacol 15 (2002) 233-238
30. Hoek K.L., Cassell G.H., Duffy L.B., and Atkinson T.P. Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells. J Allergy Clin Immunol 109 (2002) 470-476
31. Lin T.-J., Garduno R., Boudreau R.T.M., and Issekutz A.C. Pseudomonas aeruginosa activates human mast cells to induce neutrophil transendothelial migration via mast cell-derived IL-1α and β. J Immunol 169 (2002) 4522-4530
32. Dalldorf F.G., Anderle S.K., Brown R.R., and Schwab J.H. Mast cell activation by group A streptococcal polysaccharide in the rat and its role in experimental arthritis. Am J Pathol 132 (1988) 258-264
33. Supajatura V., Ushio H., Wada A., Yahiro K., Okumura K., Ogawa H., et al. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 168 (2002) 2603-2607
34. Blease K., Chen Y., Hellewell P.G., and Burke-Gaffney A. Lipoteichoic acid inhibits lipopolysaccharide-induced adhesion molecule expression and IL-8 release in human lung microvascular endothelial cells. J Immunol 163 (1999) 6139-6147
35. Schröder N.W., Morath S., Alexander C., Hamann L., Hartung T., Zähringer U., et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 278 (2003) 15587-15594
36. Hattar K., Grandel U., Moeller A., Fink L., Iglhaut J., Hartung T., et al. Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent. Toll-like-receptor-independent mechanism: autocrine role of tumor necrosis factor-α in mediating LTA-induced interleukin-8 generation. Crit Care Med 34 (2006) 835-841
37. Wang J.E., Jørgensen P.F., Almlöf M., Thiemermann C., Foster S.J., Aasen A.O., et al. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun 68 (2000) 3965-3970
38. Ellingsen E., Morath S., Flo T., Schromm A., Hartung T., Thiemermann C., et al. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med Sci Monit 8 (2002) BR149-BR156
39. English B.K., Patrick C.C., Orlicek S.L., McCordic R., and Shenep J.L. Lipoteichoic acid from viridans streptococci induces the production of tumor necrosis factor and nitric oxide by murine macrophages. J Infect Dis 174 (1996) 1348-1351
40. Genovese A., Bouvet J.P., Florio G., Lamparter-Schummert B., Bjorck L., and Marone G. Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. Infect Immun 68 (2000) 5517-5524
41. Nilsson G., Butterfield J.H., Nilsson K., and Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 153 (1994) 3717-3723
42. Nilsson G., Mikovits J.A., Metcalfe D.D., and Taub D.D. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB. Blood 93 (1999) 2791-2797
43. Hartmann K., Henz B.M., Kruger-Krasagakes S., Kohl J., Burger R., Guhl S., et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 89 (1997) 2863-2870
44. Olejnik A.K., and Brzezińska-Błaszczyk E. Tumor necrosis factor alpha (TNF-α) modulates rat mast cell reactivity. Immunol Lett 64 (1998) 167-171
45. Wong C.K., Tsang C.M., Ip W.K., and Lam C.W. Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF-α: roles of ERK, p38 MAPK, and NF-kappaB. Allergy 61 (2006) 289-297
46. Tsang C.M., Wong C.K., Ip W.K., and Lam CW. Synergistic effect of SCF and TNF-α on the up-regulation of cell surface expression of ICAM-1 on human leukemic mast cell line (HMC)-1 cells. J Leukoc Biol 78 (2005) 239-247
47. Grabbe J., Karau L., Welker P., Ziegler A., and Henz B.M. Induction of MHC class II antigen expression on human HMC-1 mast cells. J Dermatol 16 (1997) 67-73
48. Schoeler D., Grutzkau A., Henz B.M., Kuchler J., and Kruger-Krasagakis S. Interleukin-6 enhances whereas tumor necrosis factor α and interferons inhibit integrin expression and adhesion of human mast cells to extracellular matrix proteins. J Invest Dermatol 120 (2003) 795-801
49. De Rycke L., Vandooren B., Kruithof E., De Keyser F., Veys E.M., and Baeten D. Tumor necrosis factor α blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy. Arthritis Rheum 52 (2005) 2146-2158
50. Tamandl D., Bahrami M., Wessner B., Weigel G., Ploder M., Fürst W., et al. Modulation of Toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity. Shock 20 (2003) 224-229
51. Matsuguchi T., Musikacharoen T., Ogawa T., and Yoshikai Y. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol 165 (2000) 5767-5772
52. Gutierrez-Canas I., Juarranz Y., Santiago B., Arranz A., Martinez C., Galindo M., et al. VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts. Rheumatology (Oxford) 45 (2006) 527-532
53. Yoshikawa H., and Tasaka K. Caspase-dependent and -independent apoptosis of mast cells induced by withdrawal of IL-3 is prevented by Toll-like receptor 4-mediated lipopolysaccharide stimulation. Eur J Immunol 33 (2003) 2149-2159
54. Peters-Golden M., Canetti C., Mancuso P., and Coffey M.J. Leukotrienes: underappreciated mediators of innate immune responses. J Immunol 173 (2004) 589-594
55. Feghali C.A., and Wright T.M. Cytokines in acute and chronic inflammation. Front Biosci 2 (1997) 12-26